EUVIMEDEUVIMED entdecken
Open Access

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia

Yohei Hisada, Sierra J Archibald, Karan Bansal, Yanjun Chen, Chen Dai, Sindhu Dwarampudi, Nora Balas, Lindsey Hageman, Nigel S Key, Smita Bhatia, Ravi Bhatia, Nigel Mackman und 1 weitere

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2024.03.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Yohei Hisada und 12 weiteren Autor:innen. Beteiligte Einrichtung: UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, …. Hauptthemen laut MEDLINE: Hemorrhage, Venous Thromboembolism, Biomarkers, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, American Society of Hematology, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coagulopathy and associated bleeding and deep vein thrombosis (DVT) are major causes of morbidity and mortality in patients with acute leukemia. The underlying mechanisms of these complications have not been fully elucidated. OBJECTIVES: To evaluate the associations between biomarker levels and bleeding and DVT in acute leukemia patients. METHODS: We examined plasma levels of activators, inhibitors, and biomarkers of the coagulation and fibrinolytic pathways in patients aged ≥18 years with newly diagnosed acute leukemia compared with those of normal controls. Multivariable regression models were used to examine the association of biomarkers with bleeding and DVT in acute leukemia patients. The study included 358 patients with acute leukemia (29 with acute promyelocytic leukemia [APL], 253 with non-APL acute myeloid leukemia, and 76 with acute lymphoblastic leukemia) and 30 normal controls. RESULTS: Patients with acute leukemia had higher levels of extracellular vesicle tissue factor (EVTF) activity, phosphatidylserine-positive extracellular vesicles, plasminogen activator inhibitor-1, plasmin-antiplasmin complexes, and cell-free DNA and lower levels of citrullinated histone H3-DNA complexes compared with normal controls. APL patients had the highest levels of EVTF activity and the lowest levels of tissue plasminogen activator among acute leukemia patients. There were 41 bleeding and 23 DVT events in acute leukemia patients. High EVTF activity was associated with increased risk of bleeding (subdistribution hazard ratio, 2.30; 95% CI, 0.99-5.31), whereas high levels of plasminogen activator inhibitor-1 were associated with increased risk of DVT (subdistribution hazard ratio, 3.00; 95% CI, 0.95-9.47) in these patients. CONCLUSION: Our study shows alterations in several biomarkers in acute leukemia and identifies biomarkers associated with risk of bleeding and DVT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemorrhageVenous ThromboembolismBiomarkersLeukemia, Myeloid, AcuteBlood CoagulationHumansMaleMiddle AgedFemaleAdultCase-Control StudiesAgedPrecursor Cell Lymphoblastic Leukemia-LymphomaRisk FactorsLeukemia, Promyelocytic, AcuteVenous ThrombosisHistonesPlasminogen Activator Inhibitor 1ThromboplastinYoung AdultPhosphatidylserines

Stichwörter der Autor:innen

acute leukemiabiomarkerbleedingdeep vein thrombosisdisseminated intravascular coagulation

Substanzen

BiomarkersHistonesPlasminogen Activator Inhibitor 1ThromboplastinPhosphatidylserines

Autor:innen und Institutionen

  • UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Electronic address: yohei_hisada@med.unc.edu.
  • UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA; Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birming…

Förderung

  • NHLBI NIH HHS
  • American Society of Hematology
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Hisada, Y., Archibald, S. J., Bansal, K., Chen, Y., Dai, C., Dwarampudi, S., Balas, N., Hageman, L., Key, N. S., Bhatia, S., Bhatia, R., Mackman, N., & Gangaraju, R. (2024). Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.03.020

Vancouver

Hisada Y, Archibald SJ, Bansal K, Chen Y, Dai C, Dwarampudi S, et al. Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.03.020

BibTeX
@article{Hisada2024,
  author = {Hisada, Yohei and Archibald, Sierra J and Bansal, Karan and Chen, Yanjun and Dai, Chen and Dwarampudi, Sindhu and Balas, Nora and Hageman, Lindsey and Key, Nigel S and Bhatia, Smita and Bhatia, Ravi and Mackman, Nigel and Gangaraju, Radhika},
  title = {Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2024.03.020}
}
Kostenlos starten →